Gene-Editing shot takes aim at inherited high cholesterol
NCT ID NCT07353398
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new injection called ART002g1 in 24 adults with a genetic form of high cholesterol (HeFH). The injection uses gene editing to lower a protein that raises cholesterol levels. The main goal is to check safety and how well the drug works at reducing cholesterol.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai General Hospital
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a daily pill help kids with inherited high cholesterol?
- Gene-Editing heart therapy under 15-Year watch
- Real-World study tracks cholesterol drug inclisiran in heart patients
- New pill could tame inherited high cholesterol
- Gene-Editing shot could slash cholesterol for good
- Aggressive cholesterol drugs may shrink artery plaque in young patients